pDONR221_SLC6A3 Citations (3)

Originally described in: A study of the dopamine transporter using the TRACT assay, a novel in vitro tool for solute carrier drug discovery.
Sijben HJ, van den Berg JJE, Broekhuis JD, IJzerman AP, Heitman LH Sci Rep. 2021 Jan 14;11(1):1312. doi: 10.1038/s41598-020-79218-w. PubMed Journal

---

Articles Citing pDONR221_SLC6A3

Articles
A study of the dopamine transporter using the TRACT assay, a novel in vitro tool for solute carrier drug discovery. Sijben HJ, van den Berg JJE, Broekhuis JD, IJzerman AP, Heitman LH. Sci Rep. 2021 Jan 14;11(1):1312. doi: 10.1038/s41598-020-79218-w. PubMed Associated Plasmids pDONR221_SLC6A3
Screening and Validation of a Carvacrol-Targeting Viability-Regulating Protein, SLC6A3, in Liver Hepatocellular Carcinoma. Yin X, Chen H, Chen S, Zhang S. Dis Markers. 2022 Mar 30;2022:3736104. doi: 10.1155/2022/3736104. eCollection 2022. PubMed
Advancing drug discovery through assay development: a survey of tool compounds within the human solute carrier superfamily. Digles D, Ingles-Prieto A, Dvorak V, Mocking TAM, Goldmann U, Garofoli A, Homan EJ, Di Silvio A, Azzollini L, Sassone F, Fogazza M, Barenz F, Pommereau A, Zuschlag Y, Ooms JF, Tranberg-Jensen J, Hansen JS, Stanka J, Sijben HJ, Batoulis H, Bender E, Martini R, IJzerman AP, Sauer DB, Heitman LH, Manolova V, Reinhardt J, Ehrmann A, Leippe P, Ecker GF, Huber KVM, Licher T, Scarabottolo L, Wiedmer T, Superti-Furga G. Front Pharmacol. 2024 Jul 9;15:1401599. doi: 10.3389/fphar.2024.1401599. eCollection 2024. PubMed

If you have published an article using this material, please email us at to have your article added to this page.